quinoxalines has been researched along with Headache in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, A; Carrión, JA; Cornberg, M; Crown, E; Curry, M; Lampertico, P; Larsen, L; Negro, F; Pangerl, A; Persico, M; Porcalla, A; Turnes, J; Wedemeyer, H; Wick, N; Yu, Y | 1 |
| Abergel, A; Asselah, T; Gane, E; Lee, SS; Lim, SG; Mahomed, A; Mensa, FJ; Nguyen, K; Nguyen, T; Porcalla, A; Sasadeusz, J; Schnell, G; Wong, F; Yao, BB; Zadeikis, N; Zhang, Z | 1 |
| Bennett, RS; De La Garza, R; Mahoney, JJ; Newton, TF; Thompson-Lake, DG; Verrico, CD | 1 |
| Cieślewicz, A; Jabłecka, A; Korzeniowska, K | 1 |
| Brinn, MP; Carson, KV; Edwards, D; Esterman, AJ; Fitridge, R; Goldsworthy, S; Hnin, KM; Jannes, J; Koblar, SA; Litt, J; Peters, MJ; Singh, K; Smith, BJ; Veale, AJ | 1 |
| Barr, E; Ben Ari, Z; Brown, DD; Butterton, JR; DiNubile, MJ; Ghalib, R; Nguyen, BY; Pockros, PJ; Reddy, KR; Robertson, MN; Wahl, J; Wan, S; Zeuzem, S; Zhao, Y | 1 |
| Chen, H; Huang, P; Li, J; Liu, M; Wang, J; Yao, Y; Yu, R; Yue, M; Zang, F; Zhang, Y | 1 |
| Burstein, AH; Clark, DJ; Faessel, HM; Gibbs, MA; Rohrbacher, K; Stolar, M | 1 |
| Cass, LM; Dallow, NS; Jones, AE; Moore, KH; Prince, WT; Sisson, JR | 1 |
1 review(s) available for quinoxalines and Headache
| Article | Year |
|---|---|
Real-world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of patients with chronic HCV infection: A meta-analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Benzimidazoles; Cohort Studies; Drug Combinations; Fatigue; Female; Genotype; Headache; Hepacivirus; Hepatitis C, Chronic; Humans; Male; Middle Aged; Pruritus; Pyrrolidines; Quinoxalines; Sulfonamides; Sustained Virologic Response; Young Adult | 2020 |
6 trial(s) available for quinoxalines and Headache
| Article | Year |
|---|---|
Efficacy and safety of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus genotype 5 or 6 infection (ENDURANCE-5,6): an open-label, multicentre, phase 3b trial.
Topics: Adult; Aged; Aminoisobutyric Acids; Benzimidazoles; Cyclopropanes; Drug Combinations; Fatigue; Female; Genotype; Headache; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Leucine; Male; Middle Aged; Proline; Pyrrolidines; Quinoxalines; Sulfonamides; Sustained Virologic Response; Treatment Outcome; Young Adult | 2019 |
Safety and efficacy of varenicline to reduce positive subjective effects produced by methamphetamine in methamphetamine-dependent volunteers.
Topics: Adult; Amphetamine-Related Disorders; Behavior, Addictive; Benzazepines; Dose-Response Relationship, Drug; Double-Blind Method; Female; Headache; Humans; Male; Methamphetamine; Nicotinic Agonists; Quinoxalines; Treatment Outcome; Varenicline; Young Adult | 2014 |
Safety of varenicline tartrate and counseling versus counseling alone for smoking cessation: a randomized controlled trial for inpatients (STOP study).
Topics: Adult; Aged; Benzazepines; Counseling; Female; Headache; Hospitalization; Humans; Male; Middle Aged; Nausea; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; Varenicline; Young Adult | 2014 |
Grazoprevir-Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection: A Randomized Trial.
Topics: Administration, Oral; Adult; Aged; Amides; Antiviral Agents; Benzofurans; Carbamates; Cyclopropanes; Drug Administration Schedule; Drug Therapy, Combination; Fatigue; Female; Genotype; Headache; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Liver Cirrhosis; Male; Middle Aged; Nausea; Quinoxalines; Sulfonamides; Treatment Outcome; Viral Load; Young Adult | 2015 |
Multiple-dose pharmacokinetics of the selective nicotinic receptor partial agonist, varenicline, in healthy smokers.
Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Benzazepines; Cotinine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Half-Life; Headache; Humans; Hypotension, Orthostatic; Male; Metabolic Clearance Rate; Middle Aged; Nausea; Nicotine; Patient Dropouts; Quinoxalines; Receptors, Nicotinic; Smoking; Smoking Cessation; Smoking Prevention; Tablets; Varenicline; Vomiting | 2006 |
The bioavailability of the novel nonnucleoside reverse transcriptase inhibitor GW420867X is unaffected by food in healthy male volunteers.
Topics: Adult; Area Under Curve; Biological Availability; Confidence Intervals; Cross-Over Studies; Dietary Fats; Food-Drug Interactions; Gastrointestinal Diseases; Half-Life; Headache; Humans; Least-Squares Analysis; Male; Metabolic Clearance Rate; Middle Aged; Quinoxalines; Reverse Transcriptase Inhibitors | 2001 |
2 other study(ies) available for quinoxalines and Headache
| Article | Year |
|---|---|
[Safety of nicotine addiction treatment].
Topics: Abdominal Pain; Adult; Alkaloids; Azocines; Benzazepines; Boredom; Bupropion; Female; Headache; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Quinolizines; Quinoxalines; Sleep Wake Disorders; Smoking Cessation; Tobacco Use Disorder; Varenicline; Xerostomia | 2013 |
Grazoprevir and Elbasvir in Patients with Genotype 1 Hepatitis C Virus Infection: A Comprehensive Efficacy and Safety Analysis.
Topics: Amides; Antiviral Agents; Asthenia; Benzofurans; Carbamates; Cyclopropanes; Drug Therapy, Combination; Fatigue; Female; Genotype; Headache; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Male; Middle Aged; Nausea; Quinoxalines; Randomized Controlled Trials as Topic; Ribavirin; RNA, Viral; Sulfonamides; Sustained Virologic Response; Viral Load | 2017 |